First Interoperable Continuous Glucose Monitoring System Approved

The first fully interoperable continuous glucose monitoring system (CGM) approved by the The US Food and Drug Administration (FDA) helps determine the levels of blood sugar in children and adults with diabetes.

The first fully interoperable continuous glucose monitoring system (CGM) has been approved by the The US Food and Drug Administration (FDA).

The interoperable CGM helps determine the levels of blood sugar in children who are two years and older and adults with diabetes.

Drug Delivery Systems - Use in Diabetes Management
Different types of drug delivery systems for insulin delivery have been extensively researched recently. Oral route and transdermal drug delivery systems are among the advanced drug delivery systems.

‘Dexcom G6 device contains a small sensor that helps measure the amount of glucose in body fluid continuously.’

The FDA's decision to permit marketing of the Dexcom G6 integrated continuous glucose monitoring system could streamline the review pathway for similar devices.

"The ability of this device to work with different types of compatible devices gives patients the flexibility to tailor their diabetes management tools to best meet personal preferences," said Donald St. Pierre of the FDA.

Diabetes impairs the body's ability to make or properly use the blood glucose-regulating hormone insulin.

Diabetes Essentials: Types, Complications, Management & Treatment
Diabetes is a metabolic disease caused by insulin deficiency that leads to high blood sugar levels and several associated complications if left untreated.

They must regularly monitor their blood sugar levels since continuously high blood sugar levels can lead to heart disease, stroke, blindness, kidney failure and nerve damage leading to amputation of the toes, feet or legs.

Blood sugar levels can also fall too low, which can cause dizziness, confusion, unconsciousness and, in extreme cases, death.

Recent Approaches in Hypertension and Diabetes
Hypertension is defined as blood pressure is greater than equal to 140/90 mm Hg. Diabetes mellitus is a group of metabolic disorders characterized by increased blood sugar.

The Dexcom G6 is a patch device, about the size of a quarter, that is applied to the skin of the abdomen and contains a small sensor that continuously measures the amount of glucose in body fluid.

The device transmits real-time glucose readings every five minutes to a compatible display device such as a mobile medical app on a cell phone and will trigger an alarm when a patient's blood sugar enters a danger zone soaring too high or dropping too low.

Lab Test Information Key to Diabetes Management Among Albertans
A report just released by the Alberta Diabetes Surveillance System (ADSS) shows a need for more teamwork among patients and their health-care providers and more effective

If it is integrated with an automated insulin dosing system, a rise in blood sugar would trigger the release of insulin from the pump. The patch device should be replaced every 10 days.

"We listen closely to people with diabetes and continuously look for ways to empower them to better manage their condition," Dexcom CEO Kevin Sayer said in a statement after the FDA approval of the device.

"We believe the new Dexcom G6 is a significant step forward for Dexcom and our industry," Sayer said.

Source-IANS